|Aspirin therapy in primary cardiovascular disease prevention||Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin"|
|The Medical Journal of Australia||Department of Health and Human Services|
Aspirin in primary prevention of cardiovascular disease and cancer: A systematic review of the balance of evidence from reviews of randomized trials.22
|Blossom, DB; Kallen, AJ; Patel, PR; Elward, A; Robinson, L; Gao, G; Langer, R; Perkins, KM; et al||"Structural features and anticoagulant activities of a novel natural low-molecular-weight heparin from the shrimp Penaeus brasiliensis"|
|In Lichtman MA, Beutler E, Kipps TJ; et al||"Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product"|
New York Times, March 7, 2008 German Authorities Report Problems With Blood Thinner , retrieved 2008-03-07• Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis.